Don­ald Trump sends a vague­ly word­ed love let­ter to bio­phar­ma as stock ral­ly con­tin­ues

The big bio­phar­ma stock ral­ly con­tin­ued to per­co­late through Day Two of the af­ter­math of Don­ald Trump’s elec­tion. And that wasn’t hurt in the least by the pres­i­dent-elect’s promise to re­form the FDA once he gets in­to of­fice, 70 days from now.

Trump’s post-elec­tion mis­sion state­ment for his ad­min­is­tra­tion on health­care — post­ed at greata­ — starts with the re­peal of Oba­macare and goes on to make a cou­ple of vague promis­es that may well spell new ben­e­fits for the in­dus­try. In­clud­ed in that ros­ter:

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.